Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society

@article{Richard2010EstrogenAP,
  title={Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society},
  author={J. Richard and Santen},
  journal={Menopause},
  year={2010},
  volume={17},
  pages={242-255}
}
Objective: To update for both clinicians and the lay public the evidence-based position statement published by The North American Menopause Society (NAMS) in July 2008 regarding its recommendations for menopausal hormone therapy (HT) for postmenopausal women, with consideration for the therapeutic benefit-risk ratio at various times through menopause and beyond. Methods: An Advisory Panel of clinicians and researchers expert in the field of women's health was enlisted to review the July 2008… Expand
192 Citations
On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause
  • R. Langer
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2010
  • 5
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health
  • D. Sturdee, A. Pines
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2011
  • 162
  • PDF
Hormone Therapy for the Management of Menopausal Symptoms
  • 6
An update on menopausal hormone replacement therapy in women and cardiovascular disease
  • 18
Menopausal Hormone Therapy (MHT)
  • 1
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 92 REFERENCES
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
  • 143
  • PDF
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
  • 210
  • PDF
Breast cancer after use of estrogen plus progestin in postmenopausal women.
  • 303
Menopausal Hormone Therapy and Risk of Epithelial Ovarian Cancer
  • 110
  • PDF
...
1
2
3
4
5
...